Nirvana Life Sciences Inc. (CSE:NIRV)
Canada
· Delayed Price · Currency is CAD 0.1000
+0.0700 (233.33%)
Mar 26, 2025, 1:45 PM EST
-80.00% (1Y)
| Market Cap | 723.50K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -543.70K |
| Shares Out | 4.82M |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 14,589 |
| Average Volume | 1,055 |
| Open | 0.1000 |
| Previous Close | 0.0300 |
| Day's Range | 0.1000 - 0.1000 |
| 52-Week Range | 0.0300 - 0.8000 |
| Beta | 0.84 |
| RSI | 51.48 |
| Earnings Date | Apr 3, 2025 |